J Rheumatol
-
Randomized Controlled Trial Comparative Study Clinical Trial
A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
To evaluate the efficacy and tolerability of the highly selective cyclooxygenase-2 (COX-2) inhibitor etoricoxib for the treatment of rheumatoid arthritis (RA). ⋯ In this study, etoricoxib 90 mg once daily was more effective than either placebo or naproxen 500 mg twice daily for treating patients with RA over 12 weeks. Etoricoxib 90 mg was generally well tolerated in patients with RA.